NPI: 1205905361 · MOBILE, AL 36608 · Pediatric Adolescent Medicine Physician · NPI assigned 11/06/2006
Authorized official PALAZZO, ANTHONY controls 20+ related entities in our dataset. Read more
| Authorized Official | PALAZZO, ANTHONY (VICE PRESIDENT OF FINANCE) |
| NPI Enumeration Date | 11/06/2006 |
Other providers sharing the same authorized official: PALAZZO, ANTHONY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 13,419 | $444K |
| 2019 | 14,267 | $463K |
| 2020 | 8,954 | $338K |
| 2021 | 10,984 | $445K |
| 2022 | 13,205 | $510K |
| 2023 | 13,274 | $579K |
| 2024 | 10,502 | $469K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11,956 | 10,818 | $1.06M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13,904 | 12,317 | $829K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3,138 | 3,001 | $216K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2,907 | 2,815 | $204K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2,360 | 2,309 | $141K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1,569 | 1,507 | $112K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1,050 | 1,004 | $98K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 8,073 | 3,738 | $82K |
| 99215 | Prolong outpt/office vis | 1,035 | 907 | $66K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 7,625 | 6,639 | $63K |
| 90461 | 1,036 | 1,023 | $53K | |
| 99177 | 8,722 | 8,472 | $43K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 764 | 734 | $32K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2,706 | 2,546 | $32K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 324 | 319 | $30K |
| 90670 | 1,677 | 1,629 | $26K | |
| 90686 | 1,480 | 1,452 | $25K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 201 | 194 | $21K |
| 90680 | 1,256 | 1,219 | $12K | |
| 92551 | 2,324 | 2,232 | $11K | |
| 87807 | 983 | 919 | $10K | |
| 90651 | 74 | 74 | $9K | |
| 90723 | 776 | 756 | $8K | |
| 90647 | 747 | 725 | $7K | |
| 85027 | 1,454 | 1,297 | $6K | |
| 90677 | 524 | 520 | $6K | |
| 36416 | 2,527 | 2,164 | $5K | |
| 90697 | 557 | 539 | $5K | |
| 90716 | 428 | 405 | $5K | |
| 90707 | 438 | 415 | $4K | |
| 71046 | Radiologic examination, chest; 2 views | 188 | 174 | $4K |
| 90633 | 422 | 408 | $3K | |
| 99461 | 41 | 40 | $2K | |
| 0071A | 77 | 75 | $2K | |
| 90619 | 28 | 28 | $2K | |
| 90734 | 19 | 19 | $2K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 82 | 78 | $2K |
| 99051 | 278 | 267 | $2K | |
| 0072A | 46 | 46 | $2K | |
| 90656 | 64 | 64 | $1K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 13 | 12 | $1K |
| 96127 | 231 | 228 | $1K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 33 | 26 | $1K |
| 94664 | 85 | 82 | $720.00 | |
| 90715 | 28 | 28 | $588.05 | |
| 90696 | 44 | 43 | $328.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 28 | 27 | $225.00 |
| 96161 | 55 | 53 | $149.94 | |
| 82272 | 15 | 13 | $39.00 | |
| 81002 | 14 | 13 | $32.61 | |
| 85018 | 132 | 121 | $21.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 13 | 12 | $0.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 41 | 40 | $0.00 |
| S9451 | Exercise classes, non-physician provider, per session | 13 | 12 | $0.00 |